Jushi Holdings (JUSHF) EBITDA Margin (2021 - 2026)
Jushi Holdings (JUSHF) posted quarterly EBITDA Margin of 1.0% for Q2 2026, down 454.0% year-over-year from 0.28% in Q2 2025, and down 57.97% quarter-over-quarter from 2.38% in Q1 2026.
Jushi Holdings (JUSHF) EBITDA Margin (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has reported EBITDA Margin for 6 consecutive years, with 1.0% the latest figure, recorded in Q2 2026.
- In Q2 2026, EBITDA Margin fell 454.0% year-over-year to 1.0%; the TTM figure through Jun 2026 stood at 1.99% (up 197.0% YoY), while the FY2025 annual figure was 1.85%, down 237.0% from the prior year.
- EBITDA Margin eased to 1.0% in Q2 2026 per JUSHF's latest filing, from 2.38% in the prior quarter.
- Across five years, EBITDA Margin topped out at 13.01% in Q2 2024 and bottomed at 181.21% in Q4 2022.
- Historically, EBITDA Margin has averaged 15.15% across 5 years, with a median of 0.65% in 2024.
- Annual changes were most pronounced in 2022 — EBITDA Margin slumped 14170 bps — and 2023, when it jumped 17157 bps.
- Jushi Holdings' EBITDA Margin stood at 181.21% in 2022, then jumped by 95 bps to 9.64% in 2023, then surged by 71 bps to 2.79% in 2024, then soared by 141 bps to 1.14% in 2025, then fell by 12 bps to 1.0% in 2026.
- Business Quant data shows JUSHF's EBITDA Margin at 1.0% in Q2 2026, 2.38% in Q1 2026, and 1.14% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -5.58% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 33.91% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 16.51% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 42.23% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.17% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 15.80% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 18.13% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Jushi Holdings | 83.87 Mn | 50.54 Mn | 31.53 Mn | 1.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.00% |
| Mar 31, 2026 | 2.38% |
| Dec 31, 2025 | 1.14% |
| Sep 30, 2025 | 3.56% |
| Jun 30, 2025 | 5.54% |
| Mar 31, 2025 | -2.93% |
| Dec 31, 2024 | -2.79% |
| Sep 30, 2024 | 0.29% |
| Jun 30, 2024 | 13.01% |
| Mar 31, 2024 | 6.29% |
| Dec 31, 2023 | -9.64% |
| Sep 30, 2023 | 4.32% |
| Jun 30, 2023 | 5.12% |
| Mar 31, 2023 | -3.59% |
| Dec 31, 2022 | -181.21% |
| Sep 30, 2022 | -69.28% |
| Jun 30, 2022 | -16.60% |
| Mar 31, 2022 | -29.40% |
| Dec 31, 2021 | -39.51% |
| Sep 30, 2021 | -3.38% |